Patents
Patents for C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
06/2001
06/05/2001US6242030 Ginkgo Bilboa flavonoid extract which is terpene-free and has a high flavonoid heteroside content
05/2001
05/31/2001WO2001038340A1 Method of preparing clarithromycin
05/31/2001WO2001038339A1 Antimitotic compounds
05/31/2001WO2000063222A3 Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
05/31/2001US20010002400 Administering an antifungal agent
05/31/2001CA2391145A1 Method of preparing clarithromycin
05/30/2001EP1103558A2 Preparation of non-crystalline and crystalline dihydrate forms of azithromycin
05/30/2001EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols
05/30/2001EP0861242B1 Heterocyclic fungicides
05/30/2001CN1066455C Secomacrolides from class of erythromycins and process for their preparation
05/29/2001US6239113 Topical treatment or prevention of ocular infections
05/29/2001US6239112 Water miscible macrolide solutions
05/29/2001CA2156717C Solution and solid-phase formation of glycosidic linkages
05/29/2001CA2127530C Metal complexes of water soluble texaphyrins
05/25/2001WO2001036437A1 β-D-5-THIOXYLOSE DERIVATIVES, PREPARATION METHOD AND THERAPEUTIC USE
05/25/2001WO2001036434A1 Preparation of a macrocyclic lactone
05/25/2001CA2391100A1 .beta.-d-5-thioxylose derivatives, preparation method and therapeutic use
05/25/2001CA2388824A1 Preparation of a macrocyclic lactone
05/24/2001CA2290316A1 Novel source of eleutherobin and related antimitotic diterpenes
05/23/2001EP1101769A2 Nitrogen Containing Erythromycin Derivatives
05/23/2001EP1100806A1 Erythromycin derivative with antibiotic activity
05/23/2001EP1100762A2 Erythromycin derivatives with antibiotic activity
05/23/2001CN1296008A Dioxacyclopentedien-6-(5aH)-one compound, its preparation process and medicinal composition
05/22/2001US6235775 Purification; crystallization; precipitation
05/22/2001US6235294 Flavonoide esters and their use notably in cosmetics
05/16/2001EP1098901A1 Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
05/16/2001EP1098870A2 Nitric esters and nitrate salts of specific drugs
05/15/2001US6232294 Glycosyl vitamin p and trehalose; nervous system, sleep, eating, psychological, and gastrointestinal disorders
05/09/2001EP1097938A1 Method for preparing form II crystals of clarithromycin
05/09/2001EP0922051B1 Process for the production of salts of erythromycin, roxithromycin, clarithromycin and azithromycin
05/09/2001CN1294587A Benzo [B] pyran derivatives useful as external agents for skin
05/09/2001CN1294132A Process for preparing total flavone glucoside of epimedium
05/09/2001CN1294131A Process for extracting anthoxyanin from cowbeery
05/08/2001CA2226221C Cell-free synthesis of polyketides
05/08/2001CA2032141C Pharmaceutically active agents that impede amyloid formation in vivo
05/03/2001WO2001030794A1 Enzymatic substrate, synthesis method and uses
05/02/2001EP1095940A2 Derivatives of 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro[3',4':6,7]naphto[2,3-d][1,3]dioxol-6(5aH)-one, method for their preparation and pharmaceutical compositions containing them
05/02/2001EP1094822A1 Water miscible macrolide solutions
05/02/2001EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv)
05/02/2001CN1065277C Process for preparation of avermectins
05/01/2001US6224872 Flavonoid; plant extract; immunology, antiallergen
04/2001
04/28/2001CA2324495A1 New 9-(3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro ¢3',4':6,7!-naphto ¢2,3-d! ¢1,3! dioxol-6(5ah)-one derivatives, their preparation process and pharmaceutical compositions containing them
04/26/2001WO2000058328A3 Avermectin derivatives
04/18/2001EP1091971A2 Polyketides and their synthesis
04/18/2001CN1291988A Novel aromatic amides, preparation method and application as medicines
04/12/2001WO2001025246A2 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
04/12/2001CA2382830A1 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
04/11/2001EP1090123A2 Polyketides and their synthesis
04/11/2001CN1064408C Method for converting rice by using agricultural bacillsus medium to lead exogenous gene
04/10/2001US6215007 Recombinant production of novel polyketides
04/05/2001WO2001022971A1 Sebum production inhibitors
04/05/2001CA2385493A1 Sebum production inhibitors
04/04/2001EP1088828A2 Synthesis of carbamate ketolide antibiotics
04/04/2001CN1290169A Preventives and remedies for ischemic reflow disorder
04/04/2001CN1289778A Synthesis of ketonic acid lactone amino carbomate antibiotics
04/03/2001US6211348 As antibiotics
04/03/2001US6210917 By treating methylthioadenosine phosphorylase deficient cells with adenine synthesis inhibitor to deplete the target cells of adenosine 5'-triphosphate
03/2001
03/29/2001WO2001021608A2 Novel flavonoids
03/29/2001DE10021335A1 New 6-hydroxy-2,3-dihydro-1H-indole derivatives, tricyclic analogs and corresponding glycoside prodrugs, are antitumor agents for use in antibody-directed enzymatic prodrug therapy
03/28/2001EP1086953A1 Process for the purification of diosmine
03/28/2001EP1086114A2 Morphine-6-glucuronide synthesis
03/28/2001EP1085893A1 Phosphodiesterase-v modulator drugs and their uses
03/28/2001EP1085891A1 Multibinding inhibitors of topoisomerase
03/28/2001EP1085861A1 Inhibitors of nitric oxide synthase
03/28/2001EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein
03/28/2001CN1289338A 2-(purin-9-yl)-tetahydrofuran-3,4-diol derivatives
03/28/2001CN1289250A Methods of decreasing or preventing pain using spicamycin or derivatives thereof
03/28/2001CN1288896A Quercetin derivative and its medicinal use
03/27/2001US6207842 Process for preparing procyanidin(4-6 or 4-8) oligomers and their derivatives
03/27/2001US6207703 Mucoadministering to airways formulation comprising antifungal agent to reduce or eliminate symptoms of asthma
03/27/2001US6207136 Fluorescent imaging method of saccharide uptake activity of living tissue
03/22/2001WO2001019840A1 Pesticidal macrolides
03/22/2001WO2001019839A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols
03/22/2001CA2382683A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols
03/21/2001EP1083920A1 Novel antibacterial compounds
03/21/2001EP1083919A1 Novel antiviral compounds
03/21/2001EP1083899A1 METHOD OF ENHANCING LYSOSOMAL $g(a)-GALACTOSIDASE A
03/21/2001CN1063439C N-substituted 2-hetero cyclicbutanol
03/20/2001US6204376 Carbopeptides that are oligosaccharides having carbohydrate subunits linked by amide bonds and carbonucleotoids that are oligosaccharides having carbohydrate subunits linked by phosphodiester bonds; libraries
03/20/2001US6204368 Isolation of an antibiotic which is crystalized or suspended in methanol; impure antibiotic is dissolved and suspended in methanol, heated, cooled, mixed with water, concentrated and recovered
03/20/2001US6204257 Drug delivery
03/14/2001EP1082439A2 Recombinant narbonolide polyketide synthase
03/13/2001US6201752 Timing circuit for high voltage testing
03/13/2001US6200813 Altering substrate specificity of polyketide synthase by isolating genomic dna fragments which encode acyltransferase domain, transforming cell having one fragment with other fragment for homologous recombination; antibiotics
03/08/2001WO2001016148A1 Macrolide antibiotics and treatment of pasteurellosis
03/08/2001WO2001016147A1 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
03/08/2001WO1999064047A8 Novel antiviral compounds
03/07/2001CN1286633A Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
03/07/2001CN1062867C Derivs. of 12,13-epoxy-tylosin and processes for mfg. thereof
03/01/2001WO2001014397A1 9a-azalides with antibacterial activity
03/01/2001WO2001014396A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
03/01/2001WO2001014393A2 Spherical telithromycin clusters, method for the production and use thereof in the preparation of pharmaceutical forms
03/01/2001CA2345618A1 Flavonoids derived from citrus peels as collagen-induced platelet aggregation inhibitor
02/2001
02/28/2001EP1078631A1 Use of macrolide antibiotics for the treatment or prevention of coccidiosis
02/28/2001EP1077996A1 HUMAN EDG3sb GENE
02/28/2001EP1077988A1 Crystal form 0 of clarithromycin
02/28/2001EP1077987A1 Process for preparation of 4-deoxyerythromycins a and b
02/28/2001EP1077986A2 Improvements in macrolide production
02/28/2001EP1077985A1 Process for preparation of 4,5-epoxymorphinan-6-oxyglucuronides
02/28/2001CN1285841A Novel erythromycin derivatives
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 117